Inogen, Inc. (INGN)
NASDAQ: INGN · Real-Time Price · USD
9.91
-0.37 (-3.60%)
Feb 21, 2025, 4:00 PM EST - Market closed
Inogen Market Cap
Inogen has a market cap or net worth of $236.04 million as of February 21, 2025. Its market cap has increased by 36.12% in one year.
Market Cap
236.04M
Enterprise Value
135.52M
1-Year Change
36.12%
Ranking
Category
Stock Price
$9.91
Market Cap Chart
Since February 14, 2014, Inogen's market cap has decreased from $274.90M to $236.04M, a decrease of -14.14%. That is a compound annual growth rate of -1.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 236.00M | 8.06% |
| Dec 31, 2024 | 218.40M | 70.63% |
| Dec 29, 2023 | 128.00M | -71.67% |
| Dec 30, 2022 | 451.80M | -41.52% |
| Dec 31, 2021 | 772.60M | -21.82% |
| Dec 31, 2020 | 988.20M | -34.26% |
| Dec 31, 2019 | 1.50B | -43.75% |
| Dec 31, 2018 | 2.67B | 7.54% |
| Dec 29, 2017 | 2.49B | 82.61% |
| Dec 30, 2016 | 1.36B | 72.72% |
| Dec 31, 2015 | 787.90M | 34.82% |
| Dec 31, 2014 | 584.40M | 112.59% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.71B |
| UnitedHealth Group | 429.24B |
| Novo Nordisk | 391.83B |
| Johnson & Johnson | 390.76B |
| AbbVie | 356.74B |
| Abbott Laboratories | 234.01B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |